WO2026110042 - METHODS OF EXPANSION OF SKIN VDELTA1+ GAMMADELTA T CELLS AND USE OF SAME
National phase entry is expected:
Publication Number
WO/2026/110042
Publication Date
28.05.2026
International Application No.
PCT/IB2025/061816
International Filing Date
19.11.2025
Title **
[English]
METHODS OF EXPANSION OF SKIN VDELTA1+ GAMMADELTA T CELLS AND USE OF SAME
[French]
PROCÉDÉS D'EXPANSION DE LYMPHOCYTES T VDELTA1+ GAMMADELTA DE LA PEAU ET LEUR UTILISATION
Applicants **
KING'S COLLEGE LONDON
Inventors
HAYDAY, Adrian
KAMDAR, Shraddha
DAVIES, Daniel
ZLATAREVA, Iva
Priority Data
63/722,540
19.11.2024
US
63/827,068
20.06.2025
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3352 | |
| EPO | Filing, Examination, Granting | 20648 | |
| Japan | Filing, Examination, Granting | 2738 | |
| South Korea | Filing, Examination, Granting | 3298 | |
| USA | Filing, Examination, Granting | 10990 |
Total:
41,026
Contact Us
Abstract[English]
The present disclosure relates to the expansion of gamma delta (γδ) T cells, e.g., Vδ1+ γδ T cells. In particular, the present disclosure provides improved methods and processes for expanding highly active γδ T cells (e.g., Vδ1+ γδ T cells) from skin with the addition of one or more cytokines, such as IL-2, IL-15, and TGF-β.[French]
La présente divulgation concerne l'expansion de lymphocytes T gamma delta (γδ), par exemple, des lymphocytes T Vδ1+ γδ. En particulier, la présente divulgation concerne des procédés et des traitements améliorés pour l'expansion de lymphocytes T γδ hautement actifs (par exemple, des lymphocytes T Vδ1+ γδ) à partir de la peau avec l'ajout d'une ou de plusieurs cytokines, telles que l'IL-2, l'IL-15 et le TGF-β.